Revival: Delivery Strategies for Antisense Oligonucleotide Therapeutics (1995) | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Saghir Akhtar
Category1=Non-Fiction
Category=MMG
Category=TDCW
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Temporarily unavailable
Price_€100 and above
PS=Active
softlaunch

Revival: Delivery Strategies for Antisense Oligonucleotide Therapeutics (1995)

English

With contributions from leading experts, this book is the first to focus solely on addressing the problems and reviewing the strategies currently being used to improve the delivery of antisense nucleic acids. Important delivery issues, such as improving biological stability, improving cell-specific targeting and cellular uptake, manipulating subcellular distribution and producing liposomal delivery systems for antisense agents are comprehensively covered in this volume. This book links review-type articles with contributions that contain exciting never-before-published data on the cellular delivery of oligonucleotides. It stimulates reading for both established researchers and newcomers to the antisense field. See more
Current price €217.54
Original price €228.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Saghir AkhtarCategory1=Non-FictionCategory=MMGCategory=TDCWCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Temporarily unavailablePrice_€100 and abovePS=Activesoftlaunch

Will deliver when available.

Product Details
  • Weight: 780g
  • Dimensions: 156 x 234mm
  • Publication Date: 13 Jul 2017
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781138505896

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept